Form D · Biotechnology
Liquidia Technologies Inc
Morrisville, NC · CIK 0001330436
Offering snapshot reported Jan 7, 2020 · SEC filing
- Reported sold
- $22.4M Offering amount: $22.4M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 23, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 7, 2020 | Initial | $22,424,991 | No comparison | 8 | SEC filing |
| Feb 20, 2018 | Initial | $25,500,000 | No comparison | 7 | SEC filing |
| Jul 2, 2012 | Amendment | $13,799,994 | $3,799,994vs Mar 3, 2011 | 2 | SEC filing |
| Mar 3, 2011 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
| May 25, 2010 | Amendment | $25,000,010 | $5,000,007vs Jan 21, 2010 | 11 | SEC filing |
| Jan 21, 2010 | Amendment | $20,000,003 | $12,968,873vs Jul 15, 2009 | 10 | SEC filing |
| Jul 15, 2009 | Initial | $7,031,130 | No comparison | 5 | SEC filing |
| Mar 19, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 30, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 23, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.29M
- Finders' fees
- $0
- Form D file number
- 021-357336
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| JEFFERIES LLC | 2347 |
Source: Form D, filed Jan 7, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Timothy Albury | Executive |
| Stephen Bloch | Director |
| Bruce Boucher | Executive |
| Isaac Cheng | Director |
| Joseph Desimone | Director |
| Joseph De Simone | Director |
| Neal F Fowler | Director, Executive |
| Kevin Gordon | Executive |
| Florina Gordon Krawchick | Executive |
| Joanna Horobin | Director |
| Richard D Katz | Executive |
| Arthur Kirsch | Director |
| Robert Lippe | Executive |
| Ed Mathers | Director |
| Edward Mathers | Director |
| Benjamin Maynor | Executive |
| Steve Nelson | Director |
| Katherine Rielly Gauvin | Director |
| Robert Roscigno | Executive |
| Seth A Rudnick | Director |
| Jason Rushton | Director |
| Raman Singh | Director |
| Ralph Snyderman | Director |
| Jeri Thomas | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
419 Davis Drive Suite 100
Morrisville, NC, 27560
Morrisville, NC, 27560